It is a nootropic drug invented in 1996 by a team working for Merck, Sharp and Dohme, that was the first compound developed which functions to be a subtype-selective inverse agonist with the α5 subtype of the benzodiazepine binding website to the GABAA receptor. Differential advancement in overall performance with https://revivalschem.com/product/buy-1p-lsd-100-mcg-blotters/